Developing in vivo CAR T-cell therapies requires reliable approaches for transient, controlled CAR expression and targeted mRNA delivery to immune cells. This webinar will examine the transformative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback